XML 17 R169.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NOTE 20: Condensed Parent Company Only Financial Statements: Parent Company Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Changes In:      
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 38,601 $ 30,644 $ 25,618
Cash flows from investing activities:      
Net cash used in investing activities (112,992) (108,479) (123,116)
Cash flows from financing activities:      
Exercise of stock options 0 172 61
Proceeds from Issuance of Long-term Debt 0 0 (15,000)
Repayments of Long-term Debt 4,400 0 15,650
Net cash provided by financing activities 83,465 73,375 105,730
Increase (decrease) in cash and cash equivalents 9,074 (4,460) 8,232
Cash and cash equivalents at beginning of period 26,326 30,786 22,554
Cash and cash equivalents at end of period 35,400 26,326 30,786
Parent Company      
Cash Flows From Operating Activities:      
Cash Provided by (Used in) Operating Activities, Discontinued Operations 28,904 20,929 15,552
Changes In:      
Increase (Decrease) Equity in Undistributed Income of the Bank (7,427) (16,299) (12,696)
Increase (Decrease) in Other Adjustments, Net (635) 40 412
NET CASH PROVIDED BY OPERATING ACTIVITIES 20,842 4,670 3,268
Cash flows from investing activities:      
Investments in Bank subsidiaries (10,747) (3,488) (11,062)
Net cash used in investing activities (10,747) (3,488) (11,062)
Cash flows from financing activities:      
Dividends paid on common stock (4,763) (3,827) (2,981)
Exercise of stock options 0 172 61
Redemption of Common Stock Warrants (1,166) 0 0
Proceeds from Issuance of Common Stock 0 0 24,144
Proceeds from Issuance of Long-term Debt 0 0 15,000
Repayments of Long-term Debt (4,400) 0 (15,650)
Injection of capital to subsidiary 0 0 (6,000)
Net cash provided by financing activities (10,329) (3,655) 14,574
Increase (decrease) in cash and cash equivalents (234) (2,473) 6,780
Cash and cash equivalents at beginning of period 8,383 10,856 4,076
Cash and cash equivalents at end of period $ 8,149 $ 8,383 $ 10,856